Skip to main content
Figure 3 | Breast Cancer Research

Figure 3

From: Comparative evaluation of cell-free tumor DNA in blood and disseminated tumor cells in bone marrow of patients with primary breast cancer

Figure 3

LOH at the marker D3S1255 and D9S171 significantly correlate with the prevalence of recurrence. Kaplan-Meier analyses of recurrent patients with primary breast cancer (n = 76) with the occurrence of loss of heterozygosity (LOH) at the microsatellite markers (a) D3S1255 and (b) D9S171 at the time of primary diagnosis. Top curves, patients with heterozygosity at the marker D3S1255 (n = 42) and D9S171 (n = 47). Bottom curve, patients with LOH at the marker D3S1255 (n = 8) and D9S171 (n = 5).

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us